...
首页> 外文期刊>ACS Chemical Biology >Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance
【24h】

Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance

机译:多辛诱导的脂质在假单胞菌铜绿假单胞菌中的脱酰基化蛋白渗透性渗透和赋予高水平抗性

获取原文
获取原文并翻译 | 示例
           

摘要

Polymyxins are last-line antibiotics against life-threatening multidrug-resistant Gram-negative bacteria. Unfortunately, polymyxin resistance is increasingly reported, leaving a total lack of therapies. Using lipidomics and transcriptomics, we discovered that polymyxin B induced lipid A deacylation via pagL in both polymyxin-resistant and -susceptible Pseudomonas aeruginosa. Our results demonstrated that the deacylation of lipid A is an “innate immunity” response to polymyxins and a key compensatory mechanism to the aminoarabinose modification to confer high-level polymyxin resistance in P. aeruginosa . Furthermore, cutting-edge neutron reflectometry studies revealed that an assembled outer membrane (OM) with the less hydrophobic penta-acylated lipid A decreased polymyxin B penetration, compared to the hexa-acylated form. Polymyxin analogues with enhanced hydrophobicity displayed superior penetration into the tail regions of the penta-acylated lipid A OM. Our findings reveal a previously undiscovered mechanism of polymyxin resistance, wherein polymyxin-induced lipid A remodeling affects the OM packing and hydrophobicity, perturbs polymyxin penetration, and thereby confers high-level resistance.
机译:多肾上腺素是对危及生命的多药抗性革兰阴性细菌的最后抗生素。遗憾的是,多种辛抗性越来越多地报道,留下了总缺乏疗法。使用脂类动物和转录组学,我们发现多粘蛋白B通过PAGL诱导脂质诱导诱导的多脂和-SUSPIBLESPSEUDOUTONASARUGINOSA。我们的研究结果表明,脂质A的脱酰基是对多羟基苯胺的“先天免疫”反应以及氨基喹啉改性的关键补偿机制,以赋予铜绿假单胞菌在P.铜绿素中的高水平多脂素抗性。此外,与六酰基 - 酰化的形式相比,尖端中子反射测缝术研究表明,具有较少的疏水性戊酰基 - 酰化脂质的组装的外膜(OM)降低的多粘菌素B渗透。具有增强的疏水性的聚辛醛类似物显示出优异的渗透到五边形酰化脂质的尾部区域。我们的发现揭示了先前未被发现的多脂素抗性机制,其中多辛诱导的脂质进行重塑影响OM包装和疏水性,Perturbs polymyxin渗透,从而赋予高水平抗性。

著录项

  • 来源
    《ACS Chemical Biology》 |2018年第1期|共10页
  • 作者单位

    Monash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville Victoria 3052 Australia;

    Monash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville Victoria 3052 Australia;

    Monash Biomedicine Discovery Institute Monash University Clayton Victoria 3800 Australia;

    Monash Institute of Pharmaceutical Sciences Monash University 381 Royal Parade Parkville Victoria 3052 Australia;

    Australian Centre for Neutron Scattering Australian Nuclear Science and Technology Organisation Locked Bag 2001 Kirrawee DC New South Wales 2232 Australia;

    Monash Biomedicine Discovery Institute Monash University Clayton Victoria 3800 Australia;

    Department of Molecular Biology Massachusetts General Hospital Boston Massachusetts United States;

    Vertex Pharmaceuticals Boston Massachusetts United States;

    Monash Biomedicine Discovery Institute Monash University Clayton Victoria 3800 Australia;

    Monash Biomedicine Discovery Institute Monash University Clayton Victoria 3800 Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号